General posters - ishlt - The International Society for Heart & Lung ...

(503) Anti-Inflammatory Drugs Improve Mortality in Pulmonary Hypertension; J.N. Salamon, 1 M.R. Sardar, 2 W. Saeed, 2 R. Zolty. 2 1 Cardiology, Albert
Einstein College of Medicine/Montefiore Medical Center, Bronx, NY; 2 Cardiology, Montefiore Medical Center, Bronx, NY.
(504) Improved Survival with Pioglitazone in Patients with Diabetes Mellitus, Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection
Fraction: A Comparative Effectiveness Analysis; S. Shore, 1 V. Aggarwal, 1 R. Zolty. 2 1 Depaetment of Medicine, Jacobi Medical Center, Albert Einstein
College of Medicine, Bronx, NY; 2 Division of Cardiology, Dept of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
(505) Pericardial Effusion in a Patient with Pulmonary Arterial Hypertension; E.R. Fenstad, 1 G.C. Kane, 1,2 R.P. Frantz. 1,2 1 Dept of Internal Medicine,
Mayo Clinic, Rochester, MN; 2 Dept of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN; 3 Dept of Medicine, Division of
Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
(506) Value of the First Biopsy for Predicting Cardiac Allograft Vasculopathy (CAV) in Heart Transplant Patients; C.A. Labarrere, 1 J.R. Woods, 1 J.W.
Hardin, 2 G.L. Campana, 1 M.A. Ortiz, 1 B.R. Jaeger, 3 B. Reichart, 4 L.A. Baldridge, 5 J.M. Bonnin, 5 A. Currin, 6 S.K. Cosgrove, 6 P.C. Kirlin, 6 D. E. Pitts, 6 J.A.
O’Donnell, 7 D.A. Hormuth, 6 T.C. Wozniak. 6 1 Methodist Research Institute, Clarian Health Partners, Indianapolis, IN; 2 Epidemiology and Biostatistics,
Univ of South Carolina, Columbia, SC; 3 Dr. Stein und Kollegen, Mönchengladbach, Germany; 4 Ludwig-Maximilians-Universität, München, Germany;
5
Pathology and Laboratory Medicine, Indiana Univ School of Medicine, Indianapolis, IN; 6 Transplant Center, Clarian Health Partners, Indianapolis, IN;
7
Krannert Institute of Cardiology, Indianapolis, IN.
(507) Value of Early Post-Transplant Biopsies for Predicting Long-Term Major Adverse Cardiac Events (MACE) in Heart Transplant Patients; C.A.
Labarrere, 1 J.R. Woods, 1 J.W. Hardin, 2 G.L. Campana, 1 M.A. Ortiz, 1 B.R. Jaeger, 3 B. Reichart, 4 L.A. Baldridge, 5 J.M. Bonnin, 5 A. Currin, 6 S.K.
Cosgrove, 6 P.C. Kirlin, 6 D. E. Pitts, 6 J.A. O’Donnell, 7 D.A. Hormuth, 6 T.C. Wozniak. 6 1 Methodist Research Institute, Clarian Health Partners, Indianapolis,
IN; 2 Epidemiology and Biostatistics, Univ of South Carolina, Columbia, SC; 3 Dr. Stein und Kollegen, Mönchengladbach, Germany; 4 Ludwig-Maximilians-
Universität, München, Germany; 5 Pathology and Laboratory Medicine, Indiana Univ School of Medicine, Indianapolis, IN; 6 Clarian Health Transplant
Center, Clarian Health Partners, Indianapolis, IN; 7 Krannert Institute of Cardiology, Indianapolis, IN.
(508) Microvessel Density in Cardiac Allograft Biopsies in Patients with Clinically Significant Coronary Allograft Vasculopathy Treated with Sirolimus;
M.P. Revelo, J.L. Nixon, D.V. Miller, K.D. Brunisholz, T.L. Bair, M.E.H. Hammond, G.L. Snow, J. Stehlik, E.M.L. Gilbert, R.A. Alharethi, D. Budge, M.D.
Everitt, A.G. Kfoury. UTAH Cardiac Transplant Program, Salt Lake City, UT.
(509) The Role of Post-Mortem Examination in a Cardiac Transplant Program: Lessons from 101 Autopsies over 25 Years at Utah Transplant Affiliated
Hospitals; F. Isaac, D.V. Miller, M.P. Revelo, M.E.H. Hammond, J.W. Folsom, E.M. Gilbert, J. Stehlik, F.M. Bader, D. Budge, R.A. Alharethi, M.D. Everitt,
A.G. Kfoury. UTAH Cardiac Transplant Program, Salt Lake City, UT.
(510) Human Lungs Declined for Transplantation: Clinical and Pathologic Correlation; C.F. Farver, 2 H.B. Keshava, 1 J.J. Yun, 1 S.C. Murthy, 1 G.B.
Pettersson, 1 D.P. Mason. 1 1 Thoracic & Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH; 2 Anatomic Pathology, Cleveland Clinic, Cleveland, OH.
(511) Analysis of Neural and Vascular Structures across the Airway Anastomosis in Lung Transplant Recipients; A. Duarte, 1 A. Myers, 2 D.F. Dilling, 3 R.
Love, 3 V.G. Valentine, 1 G. Campbell. 1 1 UTMB, Galveston, TX; 2 Johns Hopkins Univ, Baltimore, MD; 3 Loyola Univ Medical Center, Maywood, IL.
(512) Alpha-1-Antichymotrypsin, a New Player in Reverse Remodeling of the Human Heart?; S.I. Lok, 1 N. Bovenschen, 2 R. Quadir, 2 J. van Kuik, 2 B.
Winkens, 3 M.E.I. Schipper, 2 P.A.F. Doevendans, 1 N. de Jonge, 1 R. de Weger. 2 1 Cardiology, Univ Medical Center Utrecht, Utrecht, Netherlands;
2
Pathology, Univ Medical Center Utrecht, Utrecht, Netherlands; 3 Dept Methodology Statistics, Academic Hospital Maastricht, Maastricht, Netherlands.
(513) WITHDRAWN
(514) Factors Influencing Early Onset of Coronary Allograft Vasculopathy after Orthotopic Heart Transplantation; V. Kösek, 1 H. Welp, 1 J. Osterhues, 1 J.
Stypmann, 2 H. Scheld, 1 J. Sindermann. 1 1 Thoracic and Cardiovascular Surgery, Univ Hospital, Muenster, Germany; 2 Cardiology and Angiology, Univ
Hospital, Muenster, Germany.
(515) Effect of Gender on Everolimus Treatment for Antibody-Mediated Rejection after Heart Transplantation; N.E. Hiemann, 1 E. Wellnhofer, 2 S.
Kretschmer, 1 C. Christan, 1 H. Lehmkuhl, 1 C. Knosalla, 1 R. Hetzer, 1 R. Meyer. 1 1 Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin,
Berlin, Germany; 2 Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.
(516) Seasonal Variations in Cardiac Transplant Antibody-Mediated Rejection; L. Piponniau, A. Velleca, M. Kittleson, D. Lockhart, B. Kearney, T. Kao,
M. Johnson, M. Kawano, Z. Goldstein, M. Rafiei, F. Esmailian, J. Kobashigawa. Cedars-Sinai Heart Institute, Los Angeles, CA.
(517) Pre-Transplant Strength of Circulating Antibody as Expressed in the Calculated Panel Reactive Antibody Score Predicts Antibody-Mediated
Rejection after Heart Transplant; M. Kittleson, 1 J. Patel, 1 M. Kawano, 1 Z. Goldstein, 1 M. Rafiei, 1 J. Moriguchi, 1 N. Reinsmoen, 1 E. Reed, 2 A. Hage, 1 A.
Trento, 1 J. Kobashigawa. 1 1 Cedars-Sinai Heart Institute, Los Angeles, CA; 2 Univ of California, Los Angeles, Los Angeles, CA.
(518) Success of Desensitization Protocol in Reducing Calculated Panel Reactive Antibodies in a Large Cohort of Sensitized Heart Transplant
Candidates; J. Patel, 1 J. Moriguchi, 1 E. Stimpson, 1 N. Reinsmoen, 1 E. Reed, 2 M. Kawano, 1 Z. Goldstein, 1 M. Rafiei, 1 M. Hamilton, 1 E. Schwarz, 1 J.
Kobashigawa. 1 1 Cedars-Sinai Heart Institute, Los Angeles, CA; 2 Univ of California Los Angeles, Los Angeles, CA.
(519) Does Immune System Activation from Cellular Rejection Trigger Antibody-Mediated Rejection in Heart Transplantation?; S.G. Drakos, D.R.
Verma, G.L. Snow, A. Saidi, K. Brunisholz, M.E.H. Hammond, R.A. Alharethi, J. Stehlik, M.D. Everitt, E.M. Gilbert, M.P. Revelo, D. Budge, D.V. Miller,
A.G. Kfoury. UTAH Cardiac Transplant Program, Salt Lake City, UT.
(520) Improving Results of Adult Congenital Cardiac Transplantation in the Current Era; C. Irving, 1 G. Parry, 1 R. Kirk, 1 M. Griselli, 1 A. Hasan. 1 1 Paediatric
Cardiothoracic Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom; 2 Paediatric Cardiac Intensive Care, Freeman Hospital,
Newcastle upon Tyne, United Kingdom; 3 Newcastle upon Tyne, United Kingdom.
(521) Rituximab Improves Survival in Cardiac Allograft Antibody Mediated Rejection: A Single Center Experience; A. Ravichandran, G. Ewald, J. Pfeifer,
E. Novak, S. Joseph. Cardiovascular Div. of Internal Medicine, Washington Univ Medical Center, Saint Louis, MO.
(522) Donor Specific Anti-HLA Antibodies May Not Play a Major Role in Mediating Allograft Dysfunction after Heart Transplantation; N. Shankar, M.
Gandhi, J. Geske, S. DeGoey, M. Timmons, B. Boilson, J. Schirger, A. Clavell, R. Rodeheffer, J. Wagner, R. Frantz, S. Kushwaha, R. Daly, S. Park, B.
Edwards, N. Pereira. Mayo Clinic, Rochester, MN.
(523) Post-Transplant Diastolic Dysfunction beyond the First Year: Incidence and Prognostic Significance; J. Iturrizaga, 1 S.V. Pamboukian, 1 J. George, 2
R.N. Brown, 2 M. Cadeiras, 1 M. Smallfield, 1 R.C. Bourge, 1 J.K. Kirklin, 2 D.C. McGiffin, 2 M. Hubbard, 2 J.A. Tallaj. 1,3 1 Medicine, Univ of Alabama at
Birmingham, Birmingham, AL; 2 Surgery, Univ of Alabama at Birmingham, Birmingham, AL; 3 Medicine, Birmingham VA Medical Center, Birmingham, AL.
(524) Racial and Ethnic Differences in Initial Listing Status for Heart Transplantation; D.T. Majure, 1 C. Hoopes, 2 T. De Marco, 1 K. Bibbins-Domingo. 1
1
Medicine, Univ of California, San Francisco, San Francisco, CA; 2 Surgery, Univ of California, San Francisco, San Francisco, CA.
(525) Prognostic Value of the ISHLT and DGK Working Formulations for Transplant Vasculopathy in Survival after Heart Transplantation; C. Christan, 1
E. Wellnhofer, 1 S. Kretschmer, 1 R. Meyer, 1 H.B. Lehmkuhl, 1 H.A. Valantine, 2 K.K. Khush, 2 R. Hetzer, 1 N.E. Hiemann. 1 1 Dept. of Cardiothoracic and
Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany; 2 Medical School, Stanford Univ, Stanford, CA.
(526) A Novel Surgical Technique in Heart Transplantation: Prophylactic Tricuspid Commissuro-Annuloplasty; Y. Toyoda. Univ of Pittsburgh Medical
Center, Pittsburgh, PA.